ReShape Lifesciences's total assets for Q1 2025 were $6.48M, an increase of 35.26% from the previous quarter. RSLS total liabilities were $5.25M for the fiscal quarter, a 4.10% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.